Argonaute RNA company research projects build on existing intellectual property.
Argonaute RNA has raised $1.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2026.
Argonaute RNA's investors include Development Bank of Wales, Empirical Ventures, The Fink Family Office, Bristol Private Equity Club.
Argonaute RNA is headquartered in Bristol, United Kingdom.
Argonaute RNA company research projects build on existing intellectual property.
Argonaute RNA is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Argonaute RNA — Funding & Investors." VCBacked, September 24, 2026, https://www.vcbacked.co/company/argonaute-rna. Accessed November 15, 2026.
VCBacked. (2026). Argonaute RNA — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/argonaute-rna
{{cite web |title=Argonaute RNA — Funding & Investors |url=https://www.vcbacked.co/company/argonaute-rna |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Argonaute RNA? Request a listing update